These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 34773808)
1. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma. Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808 [TBL] [Abstract][Full Text] [Related]
2. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study. Rahmati Y; Alivand M; Mollanoori H Comput Biol Chem; 2021 Jun; 92():107458. PubMed ID: 33761401 [TBL] [Abstract][Full Text] [Related]
3. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis. Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599 [TBL] [Abstract][Full Text] [Related]
4. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology. Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of potential core genes for glioblastoma. Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis. Yin X; Wu Q; Hao Z; Chen L Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915 [TBL] [Abstract][Full Text] [Related]
8. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma. Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451 [TBL] [Abstract][Full Text] [Related]
9. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma. Dong C; Fan W; Fang S J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063 [TBL] [Abstract][Full Text] [Related]
10. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis. Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116 [TBL] [Abstract][Full Text] [Related]
11. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832 [TBL] [Abstract][Full Text] [Related]
12. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis. Chen X; Pan Y; Yan M; Bao G; Sun X Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990 [TBL] [Abstract][Full Text] [Related]
13. SLC12A5 as a novel potential biomarker of glioblastoma multiforme. Chen J; Wang H; Deng C; Fei M Mol Biol Rep; 2023 May; 50(5):4285-4299. PubMed ID: 36917367 [TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma. Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792 [TBL] [Abstract][Full Text] [Related]
15. Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis. Li C; Pu B; Gu L; Zhang M; Shen H; Yuan Y; Liao L FEBS Open Bio; 2021 Mar; 11(3):833-850. PubMed ID: 33423377 [TBL] [Abstract][Full Text] [Related]
16. Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis. Yang Y; Chu L; Zeng Z; Xu S; Yang H; Zhang X; Jia J; Long N; Hu Y; Liu J Bioengineered; 2021 Dec; 12(1):6643-6654. PubMed ID: 34516348 [TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis. Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852 [TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of CPS1 in glioblastoma multiforme. Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588 [TBL] [Abstract][Full Text] [Related]
19. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis. Zhang M; Zhou Z; Liu Z; Liu F; Zhao C PeerJ; 2022; 10():e12768. PubMed ID: 35111402 [TBL] [Abstract][Full Text] [Related]
20. Computational analysis and verification of molecular genetic targets for glioblastoma. Xue L; Liu H; Chen Y; Wei L; Hong J Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]